Predicting Molecular Phenotypes with Single Cell RNA Sequencing Data: an Assessment of Unsupervised Machine Learning Models
share
According to the National Cancer Institute, there were 9.5 million cancer-related deaths in 2018. A challenge in improving treatment is resistance in genetically unstable cells. The purpose of this study is to evaluate unsupervised machine learning on classifying treatment-resistant phenotypes in heterogeneous tumors through analysis of single cell RNA sequencing(scRNAseq) data with a pipeline and evaluation metrics. scRNAseq quantifies mRNA in cells and characterizes cell phenotypes. One scRNAseq dataset was analyzed (tumor/non-tumor cells of different molecular subtypes and patient identifications). The pipeline consisted of data filtering, dimensionality reduction with Principal Component Analysis, projection with Uniform Manifold Approximation and Projection, clustering with nine approaches (Ward, BIRCH, Gaussian Mixture Model, DBSCAN, Spectral, Affinity Propagation, Agglomerative Clustering, Mean Shift, and K-Means), and evaluation. Seven models divided tumor versus non-tumor cells and molecular subtype while six models classified different patient identification (13 of which were presented in the dataset); K-Means, Ward, and BIRCH often ranked highest with 80 versus non-tumor task and 60 optimized classification pipeline using K-Means, Ward, and BIRCH models was evaluated to be most effective for further analysis. In clinical research where there is currently no standard protocol for scRNAseq analysis, clusters generated from this pipeline can be used to understand cancer cell behavior and malignant growth, directly affecting the success of treatment.
READ FULL TEXT